Japanese writing instruments manufacturer Pentel (Stationery) Ltd., is celebrating raising more than £750,000 for men’s health charity Prostate Cancer UK

In 2009 Pentel became a corporate partner of what was then The Prostate Cancer Charity. In the seventeen years of the partnership Pentel has sold more than 3.02 million pens in support of Prostate Cancer UK. If placed end to end the total length of the pens would be sufficient to scale the Burj Khalifa in Dubai, the world’s tallest building, more than 529 times.

Prostate Cancer UK funds research into earlier diagnosis, as well as making sure men understand their risk of disease, as prostate cancer is currently the only major cancer without a mass screening programme. The charity also provides professional support for men and their families affected by the disease.

Pentel marketing manager Wendy Vickery says, “Thanks to the continued support of our customers – with thanks especially to Clintons – and the generosity of the public we’re able to keep setting the goalpost higher in our bid to raise even more money for Prostate Cancer UK. We would be absolutely thrilled to reach the next fundraising target, which is £1 million and we’re determined to get there.”

James Steven, head of partnerships at Prostate Cancer UK says, “Pentel Stationery have continued to be an incredible supporter of Prostate Cancer UK over many years, and for the fundraising efforts to now tip over £750,000 since the partnership started is phenomenal. The money raised has helped fund research into earlier diagnosis and helped us reach men across the country with vital risk awareness information. We look forward to continuing this brilliant partnership and helping save men’s lives.”